GUSTAVO DAY: Open Payments
NPI 1538239173 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,181 in 250 payments from 37 companies in 2025. Trend: 2023 $5,231 · 2024 $4,730 · 2025 $5,181
Food & beverage: $5,181
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $512 |
| AstraZeneca Pharmaceuticals LP | 17 | $454 |
| SCILEX PHARMACEUTICALS INC. | 5 | $429 |
| ABBVIE INC. | 31 | $398 |
| Abbott Laboratories | 8 | $353 |
| Amgen Inc. | 25 | $335 |
| PFIZER INC. | 11 | $276 |
| Otsuka America Pharmaceutical, Inc. | 13 | $264 |
| GlaxoSmithKline, LLC. | 14 | $259 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $239 |
Products named: ZTLido, FREESTYLE LIBRE 3, ELIQUIS, JARDIANCE, REXULTI, Ozempic, EVENITY, BREZTRI.
Industry payments across TX — which companies pay providers there.
